MoneyWorks4Me

Gufic Biosciences informs about outcome of board meeting

27 Jun 2024 Evaluate
Gufic Biosciences has informed that Board of Directors of the Company at its meeting held today, June 27, 2024, considered and approved the following matters- Appointment of Kamal Kishore Seth (DIN: 00194986) as an Additional Director (Non-Executive Independent Director) of the Company, for an initial term of 5 years with effect from June 27, 2024, subject to approval of the shareholders. Further, it is hereby confirmed that Seth is not debarred from holding the office of Director by virtue of any order passed by Securities and Exchange Board of India (SEBI) or any other such authority; Resignation of Dilip Ghosh (DIN: 00412406) from the position of Whole Time Director (Key Managerial Personnel) of the Company with effect from the closing of business hours on June 27, 2024. The resignation letter of Ghosh is enclosed as Annexure-A.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1202.80
Cipla 1397.20
Lupin 2090.00
Zydus Lifesciences 1202.00
View more..